2nd Quarter - Report

NATIONAL BREAST CANCER COALITION FUND for NATIONAL BREAST CANCER COALITION FUND

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$103,910
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 9, 2015 $103,910 Replaced
2nd Quarter - Amendment Jul 14, 2015 $103,910 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Funding for the DOD peer-reviewed Breast Cancer Research Program.

LobbyistCovered position, as disclosed
DANA RICHTER Senior Legislative Assistant, Rep. Frank LoBiondo
FRANCES M VISCO —

Contacted: Natl Institutes of Health (NIH); White House Office; Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Defense Advanced Research Projects Agency (DARPA)

Medical/Disease Research/Clinical Labs MED

Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.

LobbyistCovered position, as disclosed
DANA RICHTER Senior Legislative Assistant, Rep. Frank LoBiondo
FRANCES M VISCO —

Contacted: SENATE; White House Office; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Defense Advanced Research Projects Agency (DARPA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Health Issues HCR

Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.

LobbyistCovered position, as disclosed
DANA RICHTER Senior Legislative Assistant, Rep. Frank LoBiondo
FRANCES M VISCO —

Contacted: Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Defense Advanced Research Projects Agency (DARPA); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.